Here’s your go-to guide with everything you need to know about COVID-19, including testing expanding to more airports, ...

It is much more acceptable in policy circles to talk about ways to make tax and transfer policy more progressive than ways to structure the market to ...

The Centers for Disease Control and Prevention endorsed Moderna and Pfizer’s coronavirus booster shots for ... predicts that the Food and Drug Administration will conduct a follow-up study of ...

COVID era, emphasizing innovation, oncology, and AI in drug development for potential growth. Learn more on PFE stock here.

told the BBC it has delivered more than 1,500 Pfizer doses, around 87% of which were for people who dont meet requirements for free shots. Who is eligible for a booster shot? Public health shots ...

MADISON, Wis. — Pfizer and BioNTech announced they have started a trial to determine the safety and efficacy of a third dose of its COVID-19 vaccine Thursday morning. In a statement, the ...

The FDA's full approval applies to people 16 and older. United States health authorities Monday gave full approval to the COVID-19 vaccine developed by Pfizer-BioNTech, which will now be marketed ...

Pfizer ( PFE -1.82%) isn't exactly a hot stock right now. Since its massive run-up during the pandemic's height, built on ...

Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells ...

Walensky, MD, MPH, has clarified the bottom line for single booster doses of the Pfizer-BioNTech COVID-19 vaccine. Those doses should be administered at least six months after the primary series and ...

The label expansion represents the first time an oral, two-drug single-tablet ... at the 12-week mark. Pfizer-BioNTech’s and Moderna’s mRNA-based COVID-19 vaccines have been cleared of a ...